[1]葛慧莉,徐慧.中医特色护理方案对终末期糖尿病肾病血液透析患者胃肠道症状的影响[J].西部中医药,2025,38(04):123-126.[doi:10.12174/j.issn.2096-9600.2025.04.24]
　GE Huili,XU Hui.Impacts of TCM - featured Nursing Program on Gastrointestinal Symptoms in Patients with End-stage Diabetic Nephropathy Undergoing Hemodialysis[J].Western Journal of Traditional Chinese Medicine,2025,38(04):123-126.[doi:10.12174/j.issn.2096-9600.2025.04.24]
点击复制

中医特色护理方案对终末期糖尿病肾病血液透析患者胃肠道症状的影响()
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
38
期数:
2025年04期
页码:
123-126
栏目:
临床研究
出版日期:
2025-04-15

文章信息/Info

Title:
Impacts of TCM - featured Nursing Program on Gastrointestinal Symptoms in Patients with End-stage Diabetic Nephropathy Undergoing Hemodialysis
作者:
葛慧莉, 徐慧
如皋市中医院,江苏 如皋 226500
Author(s):
GE Huili, XU Hui
Rugao Hospital of Traditional Chinese Medicine, Rugao 226500, China
关键词:
糖尿病肾病; 中医特色护理; 肠道微生态; 血液透析
Keywords:
diabetic nephropathy; TCM - characterized nursing; intestinal microecology; hemodialysis
分类号:
R255.4
DOI:
10.12174/j.issn.2096-9600.2025.04.24
文献标志码:
B
摘要:
目的分析中医特色护理方案对终末期糖尿病肾病（end stage diabetic nephropathy，ESDN）血液透析患者胃肠道症状的影响。 方法选取60例终末期ESDN血液透析患者，均于血液透析期间存在不同类型的胃肠道症状，根据随机数字表法分为对照组（30例，接受常规护理）和观察组（30例，在对照组的基础上接受中医特色护理方案），两组均干预2个月。比较两组肠道微生态、胃肠道症状、生活质量、血糖、肾功能水平。 结果干预2个月后，观察组厚壁菌门占比高于对照组（P＜0.05），拟杆菌门、变形菌门、放线菌门占比低于对照组（P＜0.05）；观察组腹痛、消化不良、便秘、腹泻、进食困难、反流评分低于对照组（P＜0.05）；观察组空腹血糖、餐后2 h血糖、24 h尿蛋白排泄率、尿素氮水平低于对照组（P＜0.05）；观察组生活质量好、生活质量一般者比率高于对照组（P＜0.05）。 结论给予ESDN血液透析患者中医特色护理方案，可改善其胃肠道菌群分布，缓解胃肠道不适症状，调节血糖水平及肾功能状态，进而促进生活质量的提高。
Abstract:
ObjectiveTo explore the influences of traditional Chinese medicine (TCM)-characterized nursing program on gastrointestinal symptoms in patients with end-stage diabetic nephropathy (ESDN) undergoing hemodialysis. MethodsSixty ESDN patients undergoing hemodialysis were chosen, having different types of gas-trointestinal symptoms during hemodialysis, and allocated to the control group (30 cases, receiving conventional care), and the observation group (30 cases, accepting TCM - characterized nursing program based on the control group), and both groups accepted two months of the intervention. To compare intestinal microecology, gastroin-testinal symptoms, quality of life, and the levels of blood glucose and renal function between the two groups. ResultsAfter two months of the intervention, the observation group was higher than the control group in the proportion of Firmicutes (P<0.05), lower than the control group in the proportions of Bacteroidetes, Proteobac-teria, and Actinobacteria (P<0.05); the scores of abdominal pain, dyspepsia, constipation, diarrhea, feeding disorder and regurgitation (P<0.05); the observation group was lower than the control group in fasting blood-glucose, 2 h postprandial plasma glucose (2 h PG), and the 24 h urine protein (24 h UP) excretion and the levels of usea nitrogen (P<0.05); the observation group was higher than the control group in the ratios of good and average quality of life (P<0.05). ConclusionTCM - characterized nursing administered to ESDN patients undergoing hemodialysis could improve the distribution of gastrointestinal flora, mitigate gastrointestinal discomforts, adjust the levels of blood glucose and renal function, so as to improve quality of life.

相似文献/References:

[1]林晓芬,黄燕璇.益肾汤联合厄贝沙坦及胰激肽原酶治疗早期糖尿病肾病的疗效观察[J].西部中医药,2013,26(07):68.
　LIN Xiaofen,HUANG Yanxuan.Clinical Observation on YiShenTang Combined with Irbesartan and Pancreatic Kininogenase in the Treatment for Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(04):68.
[2]王学琦,李丰华,张荣华,等.温肾汤治疗早期糖尿病肾病80例[J].西部中医药,2013,26(09):62.
　WANG Xueqi,LI Fenghua,ZHANG Ronghua,et al.WenShenTang for 80 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(04):62.
[3]任芳,徐厚谦△.黄芪注射液治疗糖尿病肾病有效性及安全性的系统评价[J].西部中医药,2014,27(01):77.
　REN Fang,XU Houqian.Systematic Review of the Effectiveness and Safety of HuangQi Injection in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2014,27(04):77.
[4]丁夏楠,许筠△,苏建平,等.益肾逐瘀方治疗糖尿病肾病蛋白尿37例[J].西部中医药,2014,27(04):96.
　DING Xianan,XU Jun,SU Jianping,et al.Treatment for Proteinuria of 37 Patients with Diabetic Nephropathy by Kidney-invigorating Stagnation-dispelling Prescription[J].Western Journal of Traditional Chinese Medicine,2014,27(04):96.
[5]肖远莉.循证护理的优效性及影响因素分析———来自终末期糖尿病肾病患者血液透析的证据[J].西部中医药,2014,27(08):127.
[6]刘涛.缬沙坦联合复方丹参滴丸对早期2型糖尿病肾病患者尿微量白蛋白的影响[J].西部中医药,2015,28(05):106.
[7]连琯,史晓伟.当归补血汤合金水宝治疗早期糖尿病肾病16例临床观察[J].西部中医药,2013,26(06):68.
　LIAN Guan,SHI Xiaowei.Clinical Observation on DangGui BuXueTang and JinShuiBao in Treating 16 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(04):68.
[8]任芳,徐厚谦△.黄芪注射液治疗糖尿病肾病随机对照试验报告质量评价[J].西部中医药,2013,26(12):1.
　REN Fang,XU Houqian.Quality Evaluation of the Report for Randomized Controlled Trials of HuangQi Injection in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(04):1.
[9]郭雪梅,郭秀珍△.制约中医特色护理发展的原因分析[J].西部中医药,2014,27(04):125.
　GUO Xuemei,GUO Xiuzhen.Analysis on the Reasons of Restricting the Development of TCM-featured Nursing[J].Western Journal of Traditional Chinese Medicine,2014,27(04):125.
[10]朱苗蕊,指导：金智生.糖脂平治疗早期糖尿病肾病60例疗效观察*[J].西部中医药,2013,26(03):74.
　ZHU Miaorui,Director: JIN Zhisheng.Clinical Observation on TangZhiPing in Treating 60 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(04):74.

备注/Memo

备注/Memo:
葛慧莉（1979—），女，主管护师。研究方向：心血管疾病的护理。Email：15862777761@163.com。南通市中医医疗联盟项目（TZYK202215）。
更新日期/Last Update: 2025-04-15